DEERFIELD MANAGEMENT COMPANY, L.P. Q4 2020 Filing
Filed February 16, 2021
Portfolio Value
$5.1B
Holdings
129
Report Date
Q4 2020
Filing Type
13F-HR
All Holdings (129 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | VTRSVIATRIS INC | 15,724,000 | $294.7B | 5823.73% | |
| 2 | —INVITAE CORP | 163,385,000 | $263.8B | 5214.63% | |
| 3 | —NEVRO CORP | 115,776,000 | $208.5B | 4121.48% | |
| 4 | —NUVASIVE INC | 200,000,000 | $201.3B | 3978.00% | |
| 5 | —GRAYBUG VISION INC | 5,281,713 | $153.3B | 3029.28% | |
| 6 | CNCCENTENE CORP DEL | 2,430,000 | $145.9B | 2882.99% | |
| 7 | —AERIE PHARMACEUTICALS INC | 149,600,000 | $137.1B | 2709.05% | |
| 8 | AFIBACUTUS MED INC | 4,341,799 | $125.1B | 2472.18% | |
| 9 | LRMRLARIMAR THERAPEUTICS INC | 5,144,539 | $110.1B | 2176.87% | |
| 10 | BIIBBIOGEN INC | 448,000 | $109.7B | 2168.02% | |
| 11 | SWTXSPRINGWORKS THERAPEUTICS INC | 1,442,970 | $104.6B | 2068.15% | |
| 12 | APLS 3.5 09/15/26APELLIS PHARMACEUTICALS INC | 54,825,000 | $92.5B | 1827.81% | |
| 13 | —ONCORUS INC | 2,848,977 | $92.1B | 1820.37% | |
| 14 | ALXNALEXION PHARMACEUTICALS INC | 579,248 | $90.5B | 1788.65% | |
| 15 | NKTXNKARTA INC | 1,419,872 | $87.3B | 1724.98% | |
| 16 | RYTMRHYTHM PHARMACEUTICALS INC | 2,721,203 | $80.9B | 1598.90% | |
| 17 | PODD 0.375 09/01/26INSULET CORP | 57,581,000 | $76.4B | 1510.42% | |
| 18 | INSM 1.75 01/15/25INSMED INC | 61,000,000 | $69.2B | 1368.02% | |
| 19 | AHCOADAPTHEALTH CORP | 1,806,332 | $67.8B | 1340.89% | |
| 20 | PCRXPACIRA BIOSCIENCES INC | 1,049,647 | $62.8B | 1241.38% | |
| 21 | MIRMMIRUM PHARMACEUTICALS INC | 3,448,912 | $60.2B | 1190.13% | |
| 22 | —DFP HEALTHCARE ACQUISITNS CO | 5,460,000 | $59.0B | 1165.43% | |
| 23 | OSH3EUROAK STR HEALTH INC | 951,063 | $58.2B | 1149.59% | |
| 24 | —DFP HEALTHCARE ACQUISITNS CO | 5,000,000 | $56.1B | 1107.77% | |
| 25 | RVMDREVOLUTION MEDICINES INC | 1,396,383 | $55.3B | 1092.60% | |
| 26 | XLRNACCELERON PHARMA INC | 421,619 | $53.9B | 1066.09% | |
| 27 | —DEERFIELD HEALTHCARE TECH AC | 3,418,750 | $53.3B | 1054.06% | |
| 28 | FATEFATE THERAPEUTICS INC | 564,067 | $51.3B | 1013.70% | |
| 29 | CYTKCYTOKINETICS INC | 2,461,000 | $51.1B | 1010.72% | |
| 30 | —DEERFIELD HEALTHCARE TECH AC | 3,360,000 | $50.4B | 996.09% | |
| 31 | B7SBROOKDALE SR LIVING INC | 11,023,465 | $48.8B | 965.14% | |
| 32 | —INTERCEPT PHARMACEUTICALS IN | 57,791,000 | $45.7B | 903.95% | |
| 33 | 2L9BLUEPRINT MEDICINES CORP | 405,386 | $45.5B | 898.54% | |
| 34 | —CLOVIS ONCOLOGY INC | 49,064,000 | $45.2B | 894.03% | |
| 35 | BCRXBIOCRYST PHARMACEUTICALS | 5,835,810 | $43.5B | 859.27% | |
| 36 | —CONSTELLATION PHARMCETICLS I | 1,458,957 | $42.0B | 830.43% | |
| 37 | PBYIPUMA BIOTECHNOLOGY INC | 3,959,741 | $40.6B | 802.94% | |
| 38 | MR4MERIDIAN BIOSCIENCE INC | 2,161,000 | $40.4B | 798.24% | |
| 39 | —BIODELIVERY SCIENCES INTL IN | 9,530,000 | $40.0B | 791.06% | |
| 40 | AXNX*AXONICS MODULATION TECHNOLOG | 800,000 | $39.9B | 789.28% | |
| 41 | OPHTEURIVERIC BIO INC | 5,767,409 | $39.9B | 787.64% | |
| 42 | RETAEURREATA PHARMACEUTICALS INC | 320,000 | $39.6B | 781.81% | |
| 43 | QDELUSDQUIDEL CORP | 220,000 | $39.5B | 781.12% | |
| 44 | EDITEDITAS MEDICINE INC | 538,721 | $37.8B | 746.47% | |
| 45 | OLMAOLEMA PHARMACEUTICALS INC | 696,191 | $33.5B | 661.55% | |
| 46 | 4NX1LUMOS PHARMA INC | 936,291 | $33.4B | 660.80% | |
| 47 | LUNGPULMONX CORP | 463,511 | $32.0B | 632.28% | |
| 48 | NUVAGBPNUVASIVE INC | 565,000 | $31.8B | 629.00% | |
| 49 | XERS 5 07/15/25XERIS PHARMACEUTICALS INC | 18,000,000 | $31.7B | 625.68% | |
| 50 | NVAX 3.75 02/01/23NOVAVAX INC | 25,000,000 | $31.3B | 619.12% | |
| 51 | SHCSOTERA HEALTH CO | 1,111,000 | $30.5B | 602.52% | |
| 52 | DCPHEURDECIPHERA PHARMACEUTICALS IN | 528,585 | $30.2B | 596.19% | |
| 53 | ORTXUSDORCHARD THERAPEUTICS PLC | 6,949,416 | $30.0B | 593.33% | |
| 54 | KODKODIAK SCIENCES INC | 202,406 | $29.7B | 587.67% | |
| 55 | ACHOWENS & MINOR INC NEW | 1,096,000 | $29.6B | 585.93% | |
| 56 | ANNXANNEXON INC | 1,167,826 | $29.2B | 577.71% | |
| 57 | ATECALPHATEC HLDGS INC | 2,000,000 | $29.0B | 573.94% | |
| 58 | STTKSHATTUCK LABS INC | 550,000 | $28.8B | 569.71% | |
| 59 | PTGXPROTAGONIST THERAPEUTICS INC | 1,379,971 | $27.8B | 549.83% | |
| 60 | ACCDEURACCOLADE INC | 638,001 | $27.8B | 548.50% | |
| 61 | GBIOGBXGENERATION BIO CO | 961,215 | $27.3B | 538.56% | |
| 62 | MOHMOLINA HEALTHCARE INC | 125,000 | $26.6B | 525.42% | |
| 63 | ADVMCHFADVERUM BIOTECHNOLOGIES INC | 2,404,439 | $26.1B | 515.12% | |
| 64 | BDTXBLACK DIAMOND THERAPEUTICS I | 802,511 | $25.7B | 508.32% | |
| 65 | INZYINOZYME PHARMA INC | 1,150,299 | $23.7B | 469.23% | |
| 66 | —PACIRA BIOSCIENCES INC | 20,000,000 | $22.7B | 449.01% | |
| 67 | EP3ORASURE TECHNOLOGIES INC | 2,124,515 | $22.5B | 444.45% | |
| 68 | NVRO 2.75 04/01/25NEVRO CORP | 12,000,000 | $21.9B | 433.12% | |
| 69 | —MONTES ARCHIMEDES ACQUISITIO | 2,000,000 | $21.0B | 415.04% | |
| 70 | CERTCERTARA INC | 600,000 | $20.2B | 399.86% | |
| 71 | AMWLAMERICAN WELL CORP | 791,115 | $20.0B | 396.04% | |
| 72 | PRAXPRAXIS PRECISION MEDICINES I | 350,000 | $19.3B | 380.59% | |
| 73 | TARAPROTARA THERAPEUTICS INC | 782,670 | $18.9B | 374.48% | |
| 74 | —PTC THERAPEUTICS INC | 14,527,000 | $18.6B | 367.15% | |
| 75 | —OXFORD IMMUNOTEC GLOBAL PLC | 1,049,035 | $18.3B | 362.09% | |
| 76 | —MEDAVAIL HOLDINGS INC | 1,142,552 | $17.2B | 339.84% | |
| 77 | ALGSALIGOS THERAPEUTICS INC | 600,000 | $16.6B | 327.88% | |
| 78 | ARDXARDELYX INC | 2,561,554 | $16.6B | 327.54% | |
| 79 | —VAPOTHERM INC | 604,520 | $16.2B | 320.90% | |
| 80 | ALECALECTOR INC | 1,055,192 | $16.0B | 315.53% | |
| 81 | —ITAMAR MED LTD | 793,803 | $15.8B | 311.57% | |
| 82 | AERIEURAERIE PHARMACEUTICALS INC | 1,162,033 | $15.7B | 310.27% | |
| 83 | SEMSELECT MED HLDGS CORP | 565,000 | $15.6B | 308.87% | |
| 84 | PACBPACIFIC BIOSCIENCES CALIF IN | 575,000 | $14.9B | 294.80% | |
| 85 | ZBHZIMMER BIOMET HOLDINGS INC | 95,000 | $14.6B | 289.32% | |
| 86 | BSXBOSTON SCIENTIFIC CORP | 407,000 | $14.6B | 289.18% | |
| 87 | —CODIAK BIOSCIENCES INC | 450,000 | $14.5B | 287.27% | |
| 88 | SYKSTRYKER CORPORATION | 59,000 | $14.5B | 285.72% | |
| 89 | BMRNBIOMARIN PHARMACEUTICAL INC | 163,000 | $14.3B | 282.48% | |
| 90 | PRNPROFOUND MED CORP | 695,000 | $14.3B | 282.40% | |
| 91 | SRRKSCHOLAR ROCK HLDG CORP | 288,876 | $14.0B | 277.07% | |
| 92 | —KINNATE BIOPHARMA INC | 345,000 | $13.7B | 271.24% | |
| 93 | —IMARA INC | 577,868 | $12.7B | 251.83% | |
| 94 | DYNDYNE THERAPEUTICS INC | 570,000 | $12.0B | 236.57% | |
| 95 | RNAAVIDITY BIOSCIENCES INC | 453,973 | $11.6B | 228.96% | |
| 96 | PMVPPMV PHARMACEUTICALS INC | 187,192 | $11.5B | 227.56% | |
| 97 | COGTCOGENT BIOSCIENCES INC | 1,000,000 | $11.2B | 221.95% | |
| 98 | —AVROBIO INC | 800,000 | $11.2B | 220.40% | |
| 99 | —EUCRATES BIOMEDICAL ACQU COR | 1,000,000 | $10.7B | 210.68% | |
| 100 | —SARISSA CAPITAL ACQUISITN CO | 1,000,000 | $10.7B | 210.48% |
Page 1 of 2Next